- Home
- GT vs LIVN Comparison
GT vs LIVN Comparison
Compare GT & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- LIVN
- Stock Information
- Founded
- GT 1898
- LIVN 1987
- Country
- GT United States
- LIVN United Kingdom
- Employees
- GT N/A
- LIVN N/A
- Industry
- GT Automotive Aftermarket
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GT Consumer Discretionary
- LIVN Health Care
- Exchange
- GT Nasdaq
- LIVN Nasdaq
- Market Cap
- GT 2.4B
- LIVN 2.1B
- IPO Year
- GT N/A
- LIVN 1993
- Fundamental
- Price
- GT $7.41
- LIVN $52.21
- Analyst Decision
- GT Buy
- LIVN Strong Buy
- Analyst Count
- GT 4
- LIVN 7
- Target Price
- GT $12.13
- LIVN $59.71
- AVG Volume (30 Days)
- GT 8.7M
- LIVN 544.9K
- Earning Date
- GT 11-03-2025
- LIVN 10-29-2025
- Dividend Yield
- GT N/A
- LIVN N/A
- EPS Growth
- GT N/A
- LIVN N/A
- EPS
- GT 1.47
- LIVN N/A
- Revenue
- GT $18,489,000,000.00
- LIVN $1,309,329,000.00
- Revenue This Year
- GT N/A
- LIVN $10.10
- Revenue Next Year
- GT $0.51
- LIVN $7.75
- P/E Ratio
- GT $5.02
- LIVN N/A
- Revenue Growth
- GT N/A
- LIVN 8.23
- 52 Week Low
- GT $7.38
- LIVN $32.48
- 52 Week High
- GT $12.03
- LIVN $58.91
- Technical
- Relative Strength Index (RSI)
- GT 26.62
- LIVN 44.91
- Support Level
- GT $7.41
- LIVN $49.29
- Resistance Level
- GT $7.99
- LIVN $54.25
- Average True Range (ATR)
- GT 0.22
- LIVN 1.41
- MACD
- GT -0.03
- LIVN -0.36
- Stochastic Oscillator
- GT 1.97
- LIVN 43.37
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.